Empirical Asset Management LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 15,535 shares of the company’s stock, valued at approximately $1,996,000.
Other large investors have also recently added to or reduced their stakes in the company. Danske Bank A S bought a new position in Merck KGaA during the 2nd quarter worth $276,535,000. Great Lakes Advisors LLC bought a new stake in shares of Merck KGaA in the second quarter valued at about $183,444,000. Danica Pension Livsforsikringsaktieselskab bought a new stake in shares of Merck KGaA in the second quarter valued at about $25,541,000. Diversify Advisory Services LLC acquired a new position in shares of Merck KGaA in the second quarter valued at about $3,810,000. Finally, Gables Capital Management Inc. acquired a new position in shares of Merck KGaA in the second quarter valued at about $2,095,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
OTCMKTS:MKGAF opened at $160.21 on Wednesday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm’s 50-day simple moving average is $162.32 and its 200 day simple moving average is $148.21. The firm has a market cap of $20.71 billion, a price-to-earnings ratio of 24.46 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
